Willingness to Pay for a Quality-Adjusted Life Year: Implications for Societal Health Care Resource Allocation

  title={Willingness to Pay for a Quality-Adjusted Life Year: Implications for Societal Health Care Resource Allocation},
  author={Joseph T. King and Joel Tsevat and Judith R. Lave and Mark S. Roberts},
  journal={Medical Decision Making},
  pages={667 - 677}
Background . Health-state preferences can be combined with willingness-to-pay (WTP) data to calculate WTP per quality-adjusted life year (QALY). The WTP/QALY ratios provide insight into societal valuations of expenditures for medical interventions. Methods . The authors measured preferences for current health in 3 patient populations (N = 391) using standard gamble, time trade-off, visual analog scale, and WTP, then they calculated WTP/QALY ratios. The ratios were compared with several proposed… 

Tables from this paper

Willingness to Pay per Quality-Adjusted Life Year: Is One Threshold Enough for Decision-Making?: Results From a Study in Patients With Chronic Prostatitis
Preference elicitation methods are acceptable and feasible in the socio-cultural context of an Asian environment and the calculation of WTP/QALY ratio produced meaningful answers.
Willingness to pay for a quality-adjusted life-year: the individual perspective.
Individual WTP per QALY values elicited in this study are similar to those found in comparable studies, however, the use of individual valuations in social decision-making deserves attention.
Willingness to pay for a quality-adjusted life year: an evaluation of attitudes towards risk and preferences
WTP/QALY ratios vary noticeably based on demographic and socioeconomic characteristics of the subject, but also on their attitude towards risk.
Evaluation of willingness to pay per quality-adjusted life year for a cure
This study revealed that WTP for a cure treatment was higher than that for non-cure; this higher WTP should be considered in future decision-making regarding curative treatments.
The Willingness to Pay for a Quality Adjusted Life Year: A Review of the Empirical Literature.
The results indicate that the WTP for a QALY is significantly higher if the QalY gain comes from life extension rather than quality of life improvements, and the results also show that theWTP is dependent on the size of the QALy gain valued.
The Value of a QALY: Individual Willingness to Pay for Health Gains Under Risk
Estimates of the value of a quality-adjusted life-year (QALY) are in the range of €80,000–110,000 when the weighting correction was applied, and €250,500 without correction.
Willingness to pay for a quality-adjusted life year: a systematic review with meta-regression
  • C. Kouakou, T. Poder
  • Political Science, Medicine
    The European Journal of Health Economics
  • 2021
Compared to face-to-face interviews, surveys conducted by the internet or telephone were more likely to have a significantly higher value of WTP per QALY, while out-of-pocket payment tended to lower the value.
Willingness to pay per quality-adjusted life year for life-saving treatments in Thailand
This study added another WTP per QALY value specifically for life-saving treatments, which would complement the current cost-effectiveness threshold used in Thailand and optimise patient access to innovative treatments or technologies.
A Systematic Review of Studies Eliciting Willingness-to-Pay per Quality-Adjusted Life Year: Does It Justify CE Threshold?
The variation of ratio of WTP per QALY and GDP per capita depended on several factors may prompt discussions on the CE threshold policy and provide a foundation for defining future direction of decision criteria for an evidence-informed decision making system.
WTP for a QALY and health states: More money for severer health states?
This survey shows that QALY based on the EQ-5D does not necessarily have the same monetary value, and the WTP should range from JPY 2 million (USD 20,000) to JPY 8 million ( USD 80,000), corresponding to the severity of health states.


Willingness to Pay for a Quality-adjusted Life Year
The authors determined the value of a QALY as implied by the value-of-life literature and compared this value with arbitrary thresholds for cost-effectiveness that have come into common use and far exceed the "rules of thumb" that are frequently used to determine whether an intervention produces an acceptable increase in health benefits in exchange for incremental expenditures.
Health care contingent valuation studies: a review and classification of the literature.
There is wide variation among health care CVM studies in terms of the types of questions being posed and the elicitation formats being used, and the applicability to health care of the CVM guidelines issued by the National Oceanic and Atmospheric Administration panel for environmental economics is unclear.
Relationship between quality of life instruments, health state utilities, and willingness to pay in patients with asthma.
  • K. Blumenschein, M. Johannesson
  • Medicine
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
  • 1998
Willingness to pay for hormone replacement therapy.
It is shown that the mean WTP is above the mean treatment cost of HRT and the implied WTP per gained quality adjusted life year (QALY) is estimated at about SEK 120000 and SEK 160000 based on the rating scale (RS) and time trade-off (TTO) methods, respectively.
A Cost-effectiveness Analysis of Total Hip Arthroplasty for Osteoarthritis of the Hip
For persons with hip osteoarthritis associated with significant functional limitation, THA can be cost saving or, at worst, cost-effective in improving QALE when both short- and long-term outcomes are considered and worst-case analysis suggests that THA remains minimally cost- effective for this oldest age category.
Preference-based quality of life in patients with cerebral aneurysms
Preference-based QOL instrument was moderately diminished in patients with cerebral aneurysms not assessed by functi onal status measures or patient characteristics and should be incorporated into decision analyses and cost-effectiveness analyses.
Preference-Based Quality of Life in Patients With Cerebral Aneurysms
Preference-based QOL instruments capture components of QOL in patients with cerebral aneurysms not assessed by functional status measures or patient characteristics, and should be incorporated into decision analyses and cost-effectiveness analyses.
How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.
Four "levels of evidence" that rate economic evaluations on the basis of their methodologic rigour are proposed, based on the quality of the methods used to estimate clinical effectiveness, quality of life and costs.
Health-Related Quality of Life Measurement for Evaluation Research and Policy Analysis
A unit of health status, the "Well-Year," is described, which expresses the output of health programs in terms of the number of years and the health-related "quality of life" produced by a treatment or program.
A utility maximization model for evaluation of health care programs.
A linear health utility scale is described, complete with measurement instruments, that allows assignment of utility values to health states for any disease or treatment program and is the basis of a model that will rank programs by their effectiveness/cost ratios or select them into a subset achieving the maximum effectiveness under specific cost or other constraints.